Transferred a global right of an antibody drug to a US company from a China biotech, total package worth more than $150M.
Co-developed the antibody drug with China pharma company, total package worth more than $30M.
Helped a start up biotech company to raise $ 5M pre–A round fund in China.
Helped a pharma company setting up the company in an industrialpark in China.
Helped a leading US medical organization develop go-to-market strategy and strategic partnerships in China.
Helped to hire a CEO for a start up biotech company in China.
Helped to hire a CSO for a biotech company in China.
Helped a top public Chinese pharma company to develop the global regulatory strategy and the North American market access strategy.
Copyright ©2021 BCC. All rights reserved.